Leen Rigouts

Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa

Newly Identified <i>Mycobacterium africanum</i> Lineage 10, Central Africa

Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Spot specimen testing with GeneXpert MTB/RIF results compared to morning specimen in a programmatic setting in Cotonou, Benin

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda

Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension

Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues

GWAS for quantitative resistance phenotypes in Mycobacterium tuberculosis reveals resistance genes and regulatory regions

Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase

A standardised method for interpreting the association between mutations and phenotypic drug resistance in<i>Mycobacterium tuberculosis</i>

How should discordance between molecular and growth-based assays for rifampicin resistance be investigated?

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

Genetic Determinants of Drug Resistance in <i>Mycobacterium tuberculosis</i> and Their Diagnostic Value

Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in<i>Mycobacterium tuberculosis</i>

Specific<i>gyrA</i>gene mutations predict poor treatment outcome in MDR-TB

Bedaquiline susceptibility testing of <i>Mycobacterium tuberculosis</i> in an automated liquid culture system

Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa